Print

Advanced Cancer Therapeutics Appoints Gilles Tapolsky, Ph.D. to Chief Scientific Officer  
8/19/2008 8:58:44 AM

LOUISVILLE, Ky.--(BUSINESS WIRE)--Advanced Cancer Therapeutics, LLC (ACT) announced today that industry veteran Gilles H. Tapolsky, Ph.D. has joined ACT as chief scientific officer.
//-->